|
|
||||||||
1 Departments of Human Movement and Exercise Science and 4 Medicine, The University of Western Australia, Nedlands 6907; and 2 Cardiac Transplant Unit, 3 Department of Cardiology and West Australian Heart Research Institute, Royal Perth Hospital, Perth 6000, Western Australia, Australia
| |
ABSTRACT |
|---|
|
|
|---|
This
study examined the effect of a novel circuit weight training (CWT)
program on cardiorespiratory fitness, muscular strength, and body
composition in 13 patients with chronic heart failure (CHF), using a
prospective randomized crossover protocol. Peak exercise oxygen uptake
(
O2 peak) increased
after the 8-wk CWT program (19.5 ± 1.2 vs. 22.0 ± 1.5 ml · kg
1 · min
1,
P < 0.01), as did exercise test duration (15.2 ± 0.9 vs.
18.0 ± 1.1 min, P < 0.001). Submaximal exercise heart rate
was lower after training at 60 and 80 W (121 ± 3 vs. 134 ± 5 beats/min, P < 0.01) as was rate pressure product, whereas
ventilatory threshold increased, from 52 ± 3 to 58 ± 3%
of
O2 peak (P < 0.05). CWT also increased maximal isotonic voluntary contractile
strength for seven different muscle groups, from 392 to 462 kg (P
= 0.001). CWT, an exercise prescription specifically targeting
peripheral abnormalities in CHF, improves functional capacity and
muscular strength in these patients.
chronic heart failure; exercise training; peak oxygen uptake; maximal voluntary contraction; anthropometry
| |
INTRODUCTION |
|---|
|
|
|---|
PATIENTS WITH CHRONIC HEART failure (CHF) exhibit an
impaired exercise tolerance that severely limits their functional
capacity and quality of life. Recent studies suggest that peak exercise oxygen uptake
(
O2 peak), a
measure of cardiopulmonary exercise capacity, strongly predicts
prognosis in CHF, exhibiting a higher positive correlation with
mortality than clinical indexes, including pulmonary capillary wedge
pressure and left ventricular ejection fraction (19, 27, 28). In
addition, improvement in
O2 peak is associated
with enhanced survival in patients awaiting cardiac transplantation
(29).
Although central hemodynamic abnormalities initiate and underlie the disease process, measures of cardiac function correlate poorly with exercise capacity in patients with CHF (23). A number of studies reporting skeletal muscle atrophy, changes in fiber type, and bioenergetics favoring anaerobic metabolism and impaired skeletal muscle blood flow suggest that peripheral factors may impair oxygen transport and utilization and may limit exercise performance in CHF (7, 11, 14, 24). The similarity between these peripheral abnormalities and those characteristic of prolonged inactivity or bed rest encouraged initial studies of the effect of exercise training on CHF.
It is now well established that a variety of exercise prescriptions can
improve
O2 peak and
other measures of exercise tolerance, reverse skeletal muscle
histochemical abnormalities, enhance nutritive blood flow, and possibly
improve the quality of life and clinical outcomes of patients with CHF
(2, 6, 31, 32). However, the majority of training studies have used
aerobic modalities, which improve cardiorespiratory fitness but are not
specifically targeted at skeletal muscle. Because skeletal muscle
abnormalities are an important limitation to exercise tolerance in CHF
patients (24), and muscular strength impacts their capacities to
perform daily tasks, we examined the effects of an exercise training
program combining aerobic cardiorespiratory exercise with muscular
resistance training.
| |
METHODS |
|---|
|
|
|---|
Subjects and Screening Measures
Thirteen male subjects were recruited after completing a screening program consisting of a medical history, a medical examination, and hematologic and biochemical profiles, including measurements of serum electrolytes, urea and creatinine, uric acid, liver function, and serum lipids. The following were excluded: smokers and subjects with renal impairment or proteinuria, hepatic impairment, gout, or hyperuricemia, and those with hypercholesterolemia, exercise-induced ischemia, non-insulin-dependent diabetes, or hypertension (see Table 1). Several women were screened but did not satisfy the selection criteria. Those subjects enrolled in the study had the following characteristics: 60 ± 2 (SE) yr old, 26 ± 3% ejection fraction from echocardiography and 28.7 ± 1.0 kg/m2 body mass index (BMI). Seven subjects had coronary heart disease, six had dilated cardiomyopathy, and all were in New York Heart Association class I to III. Ten patients were in sinus rhythm; the remaining three were in atrial fibrillation. No patient medications were altered during the course of the trial. The numerical breakdown of patients and their medications is as follows: angiotensin-converting enzyme inhibitors, 12; aspirin, 8; warfarin, 7; a diuretic, 6; digoxin, 4; a statin, 5; a nitrate, 3; a K+ supplement, 3; carvedilol, 2; and an antiarrhythmic drug, 2. The study protocol was approved by Royal Perth Hospital Ethics Committee, and subjects gave written, informed consent.
|
Experimental Design
Subjects were randomly assigned to either an 8-wk exercise training program or to an 8-wk nontraining period, during which they were instructed not to undertake any formal exercise. Experimental measures were assessed at entry, after 8 wk, and, following crossover, 16 wk after entry. These measures included respiratory gas-exchange assessment at submaximal steady state and at peak workloads during an incremental bicycle ergometer test, muscular strength measurement, and anthropometric assessment of body composition. Familiarization exercise tests and strength assessments were undertaken during a 2-wk lead-in period preceding randomization.Experimental Measurements
Anthropometric assessment. Body weight and height were measured before each exercise test, and BMI was calculated. Skinfolds were measured using spring-loaded calipers (Harpenden) at eight standard sites (3): triceps, biceps, subscapulare, supraspinale, iliocristale, midabdominal, anterior thigh, and medial calf. All sites were measured in triplicate, with the median score recorded. Muscle girths were similarly recorded at the following standard sites using an anthropometric steel tape (Lufkin): relaxed arm, flexed arm, waist, hip, and thigh. Waist-to-hip ratio was also calculated.
Exercise testing and respiratory gas-exchange variables. Exercise testing was undertaken on an electronically braked bicycle ergometer (Orival 400, Lode), with initial resistance set at 20 W and increased stepwise in 20-W increments every 3 min. Heart rate (HR) and rhythm were continuously recorded by 12-lead electrocardiogram, and blood pressure was measured during the last 30 s of each 3-min stage. Arterial oxygen saturation was continuously monitored using a pulse oximeter (Oxypleth 520A, Oximetrics), and subjects reported their rating of perceived exertion (RPE) on the 15-point Borg scale at the end of each 3 min stage.
The volumes of oxygen consumed (
O2) and carbon dioxide
produced (
CO2) during
exercise were calculated from minute ventilation (
E), measured using mass flow
ventilometry and simultaneous mixing chamber analysis of expired gas
fractions (
max, Sensormedics). Gas
analyzers and flow probes were calibrated before each test.
O2 and
CO2 were recorded during
the final 40 s of each stage of the test and expressed in liters per
minute and relative to body weight
(ml · kg
1 · min
1).
O2 peak was
calculated as the average of the two highest consecutive 20-s periods
of gas-exchange data occurring in the last minute before volitional
exhaustion, which generally occurred due to leg fatigue or
breathlessness. Rate pressure product (RPP) was calculated at the end
of each stage of exercise as the product of submaximal HR
and systolic blood pressure, while oxygen pulse (O2pulse)
was calculated by dividing
O2 by HR. The ventilatory threshold (Tvent) was assessed by two investigators using a
combination of break points in the relationship between
O2 and
CO2 (the V-slope method)
and a systematic increase in the
E/
O2
without a concomitant increase in
E/
CO2.
Assessment of muscular strength. Maximal isotonic voluntary contractile strength (MVC) was assessed for 7 distinct muscle groups (MVC7) using the one-repetition-maximum (1- RM) technique and custom-designed, pin-loaded weight stack resistance equipment (Pulsestar, Cheshire, UK), with minimum 2.5 kg-increments. These machines were also used during the exercise training program. The seven resistance exercises consisted of dual-seated leg press, left and right hip extension, pectoral exercises, shoulder extension, seated abdominal flexion, and dual-leg flexion. Subjects were instructed in correct lifting techniques, to avoid Valsalva maneuver and hand gripping. MVC7 was calculated as the sum of strength measures on each apparatus.
Exercise Training Regime
The exercise intervention was structured and supervised by an experienced exercise physiologist in a dedicated gymnasium at Royal Perth Hospital. The 8-wk training regime consisted of three, 1-h sessions of whole body exercise each week, concentrating on the large muscle groups of the lower limbs with selected torso and upper body exercises also included. Each of these sessions commenced and concluded with a l0-min warm-up or cooldown and stretching period.The conditioning phase of each session involved circuit weight training (CWT), a combination of cycle ergometry, treadmill walking, and resistance weight training. An exercise circuit consisted of seven resistance exercises alternated with eight aerobic exercise (cycling) stations. Each exercise was performed for 45 s, with 15-s intervals, signaled by a timer, for the purpose of moving to the next station. To conclude the circuit, subjects spent 5 min walking on a treadmill. The active recovery (aerobic cycling) exercise between resistance stations was designed to maintain exercise HR within the training zone and to facilitate changes in cardiorespiratory fitness. Intensity and duration of the exercise program were progressively increased throughout the 8- wk program, as individually tolerated. Initially, this was done by increasing the number of exercise circuits from one to three, followed by increasing the resistance or cycling load.
Resistance training intensity commenced at 55% of pretraining MVC7, as determined from initial 1-RM strength tests, and increased to 65% by week 4 of the program. Cycle ergometry and treadmill walking commenced at 70% of the peak HR observed during the initial incremental exercise test and increased to 85% by week 6. During resistance exercise, subjects were instructed to perform one complete exercise every 3 s, resulting in 15 repetitions in 45 s.
Treatment and Analysis of Data
Results are expressed as means ± SE. The responses after exercise training were compared with nontraining responses using Student's paired t-tests.| |
RESULTS |
|---|
|
|
|---|
Six of the thirteen patients were randomized to receive exercise training during the first 8 wk, seven during the last 8 wk. All patients completed 24 exercise sessions. No significant adverse events occurred during exercise testing procedures or training sessions.
Comparison of Subject Characteristics
There were no significant differences in resting HR or systolic, diastolic, or mean arterial pressures after exercise training (Table 1). In addition, no differences were evident in plasma total cholesterol, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, or triglyceride concentrations following training.Anthropometric Assessment and Muscular Strength
Anthropometric and strength data are presented in Table 2. Exercise training significantly enhanced MVC7 from 392 to 462 kg (P = 0.001). Body weight did not significantly decrease after training, and, although the sum of skinfolds decreased on average, this difference did not achieve statistical significance. Changes in muscle girths, BMI, and waist-to-hip ratio were also insignificant.
|
Peak and Submaximal Exercise Test Data
Exercise training was associated with significant increase in
O2 peak, from 19.5 ± 1.2 to 22.0 ± 1.5 ml · kg
1 · min
1
(P < 0.01, Fig. 1), also evident
when
O2 peak
data were expressed in absolute terms; 1.7 ± 0.1 to 1.9 ± 0.1 l/min
(P < 0.01). Exercise test duration improved from 15.2 ± 0.9 to 18.0 ± 1.1 min (P < 0.001, Fig. 1) and peak
O2pulse increased from 0.127 ± 0.006 to 0.144 ± 0.007 ml · kg
1 · beats
1 · min
1
(P < 0.01). Peak HR (151 ± 5 vs. 154 ± 6 beats/min,
P < 0.4), RPP (26,323 ± 1,273 vs. 25,823 ± 1,578, beats · min
1 · mmHg,
P = 0.6), and RPE (17 ± 2 vs. 16 ± 1, P = 0.8) did
not significantly differ after training.
|
All subjects completed all exercise test workloads up to, and
including, 60 W. Eleven patients completed 80 W, eight completed 100 W,
and three completed 120 W. HR was significantly lower after training at
60 (108 ± 3 vs. 120 ± 4 beats/min, P < 0.01) and 80 W
(121 ± 3 vs. 134 ± 5 beats/min, P < 0.01). RPP was also
significantly lower at 60 (15,153 ± 651 vs. 18,110 ± 1,241 beats · min
1 · mmHg,
P < 0.05) and 80 W (18,851 ± 988 vs. 21,363 ± 1,386 beats · min
1 · mmHg,
P < 0.05), whereas RPE did not differ at any workload. The
Tvent occurred at a higher relative proportion of
O2 peak after training
(52 ± 3 vs. 58 ± 3%, P < 0.05).
Figure 2 depicts trained and untrained
O2 peak data according
to order of administration of exercise training, comparing those who
received exercise training first with those who trained second. The
effect of exercise training on
O2 peak was not
different between these subgroups (P < 0.6). Figure
3 presents a similar analysis of the
strength data. The difference between trained and untrained
MVC7 was, on average, less in those who trained first,
although not significantly so (P < 0.3), suggesting
that persistence of the training effect on this parameter was not
significant. On this basis, data from both training groups were
pooled.
|
|
| |
DISCUSSION |
|---|
|
|
|---|
Peak exercise capacity, assessed by
O2 peak, is the best
predictor of survival in patients with CHF (19). In addition, increases
in functional capacity in these patients is associated with improved
quality of life and is possibly associated with improved prognosis (2).
Exercise training programs aimed at improving exercise capacity in
patients with CHF should, therefore, be designed to specifically target
the limitations of functional capacity in these patients. In recent
years, it has become evident that peripheral skeletal muscle
abnormalities are responsible for exercise limitation in many patients
with CHF (4, 7). Although previous controlled trials have demonstrated
beneficial effects following exercise training, the majority of these
have utilized prolonged, repetitive, dynamic aerobic modalities that are often poorly tolerated due to localized muscle fatigue. Other exercise prescriptions specifically targeting the peripheral
abnormalities present in heart failure have not been investigated. In
the present study, we hypothesized that, due to its interval nature and
the rotation between active muscle groups, CWT would be well tolerated by patients, minimize localized muscle fatigue, and combine the beneficial effects of both aerobic conditioning and skeletal muscle strength training. The major finding is that CWT improves
cardiorespiratory fitness and muscular strength in patients with CHF.
This study is unique because it documents the occurrence of adaptations
in response to brief, alternating bouts of aerobic and resistance exercise that involve different muscle groups and are separated by
minimal periods of rest.
Respiratory gas analysis during exercise revealed significant
improvement in
O2 peak.
The magnitude of this improvement (~13%) compares favorably with
previous trials that used aerobic exercise modalities such as cycling,
walking, and running over a time period of similar length (5, 6, 12).
Unlike many of these previous trials, all patients in this trial
undertook a peak exercise test during the 2-wk lead-in period that
preceded the initial experimental measure. This was done to ensure that patients were familiar with the test procedures and that a learning effect did not influence the results. Studies reporting larger improvements in exercise capacity as a result of exercise training have
typically taken place over a longer time span or have not reported
familiarization procedures (2, 8, 10, 13).
Traditionally, resistance exercise has been avoided in CHF because of fears that it may increase hemodynamic burden, decrease myocardial perfusion, or cause wall motion abnormalities or arrhythmias (21). However, in one study that compared hemodynamic responses to both resistance exercise and continuous aerobic exercise (cycling) of similar relative intensities, the resistance modality was associated with favorable responses (22). In addition, studies performed after myocardial infarction indicate decreased ischemia during resistance when compared with aerobic exercise, possibly due to improved coronary artery filling as a result of increased diastolic pressure in combination with decreased HR (21). In accordance with these findings, it should be noted that the exercise modality in the present study, a moderate-intensity resistance training program, was well tolerated by closely supervised and monitored patients and resulted in no adverse events.
A recent nonrandomized trial that investigated the effects of
high-intensity knee extensor exercise in CHF patients reported significant improvements in muscle strength, capillarization, and
oxidative capacity of the trained muscle group (16), indicating improvement in localized skeletal muscle function in response to
training. However, peak exercise responses were not
measured in that trial. The present study is the first to demonstrate
that a circuit training program structured with alternating bouts of aerobic and resistance exercise, separated by minimal rest periods, maintains HR and
O2 within an
effective training zone throughout the exercise session,
leading to an enhancement of aerobic capacity. In contrast, consecutive
bouts of resistance exercise alone, separated by relatively long
periods of rest, have not been shown to have an effect on aerobic capacity.
Improvement in submaximal data was also evident following CWT. RPP was
lower after training, suggesting that myocardial oxygen demand
decreased. This may have resulted from increased peripheral vasodilation and, consequently, decreased afterload following exercise,
a result supported by recent findings that exercise training improves
resistance vessel dilatation in CHF (18). Because the vascular benefits
of exercise training are not limited to the skeletal muscle bed
involved in the exercise stimulus, it is also possible that epicardial
coronary vasodilation during exercise increases after training. In
addition to changes in RPP, submaximal HR was lower after training,
further suggesting improved cardiorespiratory fitness. Finally, the
percentage of
O2 peak at which Tvent occurred increased significantly after
training, indicating that patients could train at higher submaximal
exercise intensities before the onset of blood lactic acid accumulation.
The increase in muscular strength is also of clinical relevance.
Patients with CHF exhibit skeletal muscle atrophy and impaired muscular
strength (15, 17, 20, 26). Although previous studies have reported
changes in skeletal muscle histology and biochemistry as a result of
training (1, 9, 25, 30, 31), ours is the first controlled trial to
report generalized improvement in skeletal muscle strength; seven
isolated muscle strength sites were assessed, with improvement evident
at each. This has important implications for patient capacity to
perform tasks of daily living, many of which are dependent on muscular strength, and indicates that CWT is an effective modality for improving
peripheral muscle function in addition to
O2 peak.
It is possible, from the results of this crossover trial, to determine
whether the effects of CWT on strength and
O2 peak persist after
the cessation of exercise. The data suggest that improvement in
strength persists longer than that for
O2 peak, although the
effect of CWT was not fully sustained for either. Therefore, it is
likely that patients need to maintain a regular regime of exercise to
preserve the benefits of CWT, although previous data suggest that such
benefits may be sustained with a reduced exercise commitment (2).
It is pertinent to mention certain limitations of the present study.
Patients with severe heart failure were not included; thus the results
cannot necessarily be extrapolated to those subjects. In addition, most
patients were not receiving
-blocking therapy because the study
commenced before these agents were frequently administered for the
management of heart failure. Although several women were screened for
the study, none satisfied the inclusion criteria, and the conclusions
may have no pertinence to women. Finally, the use of sophisticated
imaging techniques, such as dual-energy X-ray absorptiometry, may have
provided more precise information regarding changes in body
composition. Traditionally, skinfold and girth measurements have been
accepted for this purpose, and we took care to collect multiple
measures from a range of sites. However, the increase in muscle
strength we observed does not necessarily infer increased muscular hypertrophy.
In conclusion, it is now widely acknowledged that exercise training is an important component of the management of CHF that can improve functional capacity, quality of life, and prognosis. The results of this study suggest that CWT, an exercise training modality that specifically targets the peripheral limitations to exercise tolerance evident in patients with CHF, improves cardiorespiratory fitness and skeletal muscle strength. Although our program was formal and structured, a simplified program combining aerobic and resistance components should provide similar benefits that could be associated with improved prognosis and an increased capacity to perform tasks of daily living.
| |
ACKNOWLEDGEMENTS |
|---|
This study was supported by the National Heart Foundation (Australia) and Medical Research Fund of Western Australia.
| |
FOOTNOTES |
|---|
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact.
Address for reprint requests and other correspondence: D. Green, Dept. of Human Movement, The Univ. of Western Australia, Nedlands 6907, Western Australia, Australia.
Received 13 July 1999; accepted in final form 16 December 1999.
| |
REFERENCES |
|---|
|
|
|---|
1.
Adamopoulos, S,
Coats AJ,
Brunotte F,
Arnolda L,
Meyer T,
Thompson CH,
Dunn JF,
Stratton J,
Kemp GJ,
Radda GK,
and
Rajagopalan B.
Physical training improves skeletal muscle metabolism in patients with chronic heart failure.
J Am Coll Cardiol
21:
1101-1106,
1993[Abstract].
2.
Belardinelli, R,
Georgiou D,
Cianci G,
and
Purcaro A.
Randomized, controlled trial of long-term moderate exercise training in chronic heart failure: effects on functional capacity, quality of life, and clinical outcome.
Circulation
99:
1173-1182,
1999
3.
Bloomfield, J,
Ackland TR,
and
Elliott BC.
Applied Anatomy and Biomechanics in Sport. Melbourne, Australia: Blackwell Scientific, 1994.
4.
Clark, AL,
Poole-Wilson PA,
and
Coats AJ.
Exercise limitation in heart failure: central role of the periphery.
J Am Coll Cardiol
28:
1092-1102,
1996[Abstract].
5.
Coats, AJ,
Adamopolous S,
Meyer T,
Conway J,
and
Sleight P.
Effects of physical training in chronic heart failure.
Lancet
335:
63-66,
1990[Web of Science][Medline].
6.
Coats, AJ,
Adamopoulos S,
Radaelli A,
McCance A,
Meyer TE,
Bernardi L,
Solda PL,
Davey P,
Ormerod O,
Forfar C,
Conway J,
and
Sleight P.
Controlled trial of physical training in chronic heart failure. Exercise performance, hemodynamics, ventilation, and autonomic function.
Circulation
85:
2119-2131,
1992
7.
Drexler, H,
Reide U,
Munzel T,
Konig H,
Funke E,
and
Just H.
Alterations of skeletal muscle in chronic heart failure.
Circulation
85:
1751-1759,
1992
8.
Hambrecht, R,
Fiehn E,
Weigl C,
Gielen S,
Hamann C,
Kaiser R,
Yu J,
Adams V,
Niebauer J,
and
Schuler G.
Regular physical exercise corrects endothelial dysfunction and improves exercise capacity in patients with chronic heart failure.
Circulation
98:
2709-2715,
1998
9.
Hambrecht, R,
Fiehn E,
Yu J,
Niebauer J,
Weigl C,
Hilbrich L,
Adams V,
Riede U,
and
Schuler G.
Effects of endurance training on mitochondrial ultrastructural and fiber type distribution in skeletal muscle of patients with stable chronic heart failure.
J Am Coll Cardiol
29:
1067-1073,
1997[Abstract].
10.
Hambrecht, R,
Neibauer J,
Fiehn E,
Kalberer B,
Offner B,
Hauer K,
Reide U,
Schlierf G,
Kubler W,
and
Schuler G.
Physical training in patients with stable chronic heart failure: effects on cardiorespiratory fitness and ultrastructural abnormalities of leg muscles.
J Am Coll Cardiol
25:
1239-1249,
1995[Abstract].
11.
Harrington, D,
and
Coats AJ.
Mechanisms of exercise intolerance in congestive heart failure.
Curr Opin Cardiol
12:
224-232,
1997[Web of Science][Medline].
12.
Jette, M,
Heller R,
Landry F,
and
Blumchem G.
Randomized 4-week exercise program in patients with impaired left ventricular function.
Circulation
84:
1561-1567,
1991
13.
Keteyian, SJ,
Levine AB,
Brawner CA,
Kataoka T,
Rogers FJ,
Schairer JR,
Stein PD,
Levine TB,
and
Goldstein S.
Exercise training in patients with heart failure. A randomized, controlled trial.
Ann Intern Med
124:
1051-1057,
1996
14.
Kraemer, MD,
Kubo SH,
Rector TS,
Brunsvold N,
and
Bank AJ.
Pulmonary and peripheral vascular factors are important determinants of peak exercise oxygen uptake in patients with heart failure.
J Am Coll Cardiol
21:
641-648,
1993[Abstract].
15.
Lipkin, DP,
Jones DA,
Round JM,
and
Poole-Wilson PA.
Abnormalities of skeletal muscle in patients with chronic heart failure.
Int J Cardiol
18:
187-195,
1988[Web of Science][Medline].
16.
Magnussen, G,
Gordon A,
Kaijser L,
Sylven C,
Isberg B,
Karpakka J,
and
Saltin B.
High intensity knee extensor training, in patients with chronic heart failure. Major skeletal muscle improvement.
Eur Heart J
17:
1048-1055,
1996
17.
Magnussen, G,
Isbeg B,
Karlberg KE,
and
Sylven C.
Skeletal muscle strength and endurance in chronic congestive heart failure secondary to idiopathic dilated cardiomyopathy.
Am J Cardiol
73:
307-309,
1994[Web of Science][Medline].
18.
Maiorana, A,
O'Driscoll G,
Rankin S,
Waddy P,
Goodman C,
Taylor R,
and
Green D.
Effect of circuit weight training on functional capacity, strength and vascular function in patients with heart failure.
Circulation
98:
I-774,
1998.
19.
Mancini, DM,
Eisen H,
Kussmaul W,
Mull R,
Edmunds LH, Jr,
and
Wilson JR.
Value of peak exercise oxygen consumption for optimal timing of cardiac transplantation in ambulatory patients with heart failure.
Circulation
83:
778-786,
1991
20.
Mancini, DM,
Walter G,
Reicheck N,
Lenkinski R,
McCully KK,
Mullen JL,
and
Wilson JR.
Contributions of skeletal muscle atrophy to exercise intolerance and altered muscle metabolism in heart failure.
Circulation
85:
1364-1373,
1992
21.
McCartney, N.
Role of resistance training in heart disease.
Med Sci Sports Exerc
30:
S396-S402,
1998[Web of Science][Medline].
22.
McKelvie, RS,
McCartney N,
Tomlinson C,
Bauer R,
and
MacDougall JD.
Comparison of hemodynamic responses to cycling and resistance exercise in congestive heart failure secondary to ischemic cardiomyopathy.
Am J Cardiol
76:
977-979,
1995[Web of Science][Medline].
23.
McKelvie, RS,
Teo KK,
McCartney N,
Humen D,
Montague T,
and
Yusuf S.
Effects of exercise training in patients with congestive heart failure: a critical review.
J Am Coll Cardiol
25:
789-796,
1995[Abstract].
24.
Minotti, JR,
Christoph I,
Oka R,
Weiner MW,
Wells L,
and
Massie BM.
Impaired skeletal muscle function in patients with congestive heart failure. Relationship to systemic exercise performance.
J Clin Invest
88:
2077-2082,
1991.
25.
Minotti, JR,
Johnson EC,
Hudson TL,
Zuroske G,
Murata G,
Fukushima E,
Cagle TG,
Chick TW,
Massie BM,
and
Icenogle MV.
Skeletal muscle response to exercise training in congestive heart failure.
J Clin Invest
86:
751-758,
1990.
26.
Minotti, JR,
Pillay P,
Oka R,
Wells L,
Christoph I,
and
Massie BM.
Skeletal muscle size: relationship to muscle function in heart failure.
J Appl Physiol
75:
373-381,
1993
27.
Myers, J,
Gullestad L,
Vagelos R,
Do D,
Bellin D,
Ross H,
and
Fowler MB.
Clinical, hemodynamic, and cardiopulmonary exercise test determinants of survival in patients referred for evaluation of heart failure.
Ann Intern Med
129:
286-293,
1998
28.
Opasich, C,
Pinna GD,
Bobbio M,
Sisti M,
Demichelis B,
Febo O,
Forni G,
Riccardi R,
Riccardi PG,
Capomolla S,
Cobelli F,
and
Tavazzi L.
Peak exercise oxygen consumption in chronic heart failure: toward efficient use in the individual patient.
J Am Coll Cardiol
31:
766-775,
1998
29.
Stevenson, LW,
Steimle AE,
Foranow G,
Kermani M,
Kermani D,
Hamilton MA,
Moriguchi JD,
Walden J,
Tillisch JH,
Drinkwater DC,
and
Laks H.
Improvement in exercise capacity of candidates awaiting heart transplantation.
J Am Coll Cardiol
25:
163-170,
1995[Abstract].
30.
Sullivan, MJ,
Green HJ,
and
Cobb FR.
Altered skeletal muscle metabolic response to exercise in chronic heart failure. Relation to skeletal muscle aerobic enzyme activity.
Circulation
84:
1597-1607,
1991
31.
Sullivan, MJ,
Higginbotham MB,
and
Cobb FR.
Exercise training in patients with severe left ventricular dysfunction. Hemodynamic and metabolic effects.
Circulation
78:
506-515,
1988
32.
Tyni-Lenne, R,
Gordon A,
Europe E,
Jansson E,
and
Sylven C.
Exercise-based rehabilitation improves skeletal muscle capacity, exercise tolerance, and quality of life in both women and men with chronic heart failure.
J Card Fail
4:
9-17,
1998[Medline].
This article has been cited by other articles:
![]() |
C. O. Weiss, H. H. Hoenig, R. Varadhan, E. M. Simonsick, and L. P. Fried Relationships of Cardiac, Pulmonary, and Muscle Reserves and Frailty to Exercise Capacity in Older Women J Gerontol A Biol Sci Med Sci, October 12, 2009; (2009) glp147v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
M A Spruit, R-M A Eterman, V A C V Hellwig, P P Janssen, E F M Wouters, and N H M K Uszko-Lencer Effects of moderate-to-high intensity resistance training in patients with chronic heart failure Heart, September 1, 2009; 95(17): 1399 - 1408. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. S. Evans, C. L. Battaglini, D. G. Groff, and A.C. Hackney Aerobic Exercise Intensity in Breast Cancer Patients: A Preliminary Investigation Integr Cancer Ther, June 1, 2009; 8(2): 139 - 147. [Abstract] [PDF] |
||||
![]() |
A. V. N. Bacurau, M. A. Jardim, J. C. B. Ferreira, L. R. G. Bechara, C. R. Bueno Jr., T. C. Alba-Loureiro, C. E. Negrao, D. E. Casarini, R. Curi, P. R. Ramires, et al. Sympathetic hyperactivity differentially affects skeletal muscle mass in developing heart failure: role of exercise training J Appl Physiol, May 1, 2009; 106(5): 1631 - 1640. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Mandic, W. Tymchak, D. Kim, B. Daub, H A. Quinney, D. Taylor, S. Al-Kurtass, and M. J Haykowsky Effects of aerobic or aerobic and resistance training on cardiorespiratory and skeletal muscle function in heart failure: a randomized controlled pilot trial Clinical Rehabilitation, March 1, 2009; 23(3): 207 - 216. [Abstract] [PDF] |
||||
![]() |
P. J. Beckers, J. Denollet, N. M. Possemiers, F. L. Wuyts, C. J. Vrints, and V. M. Conraads Combined endurance-resistance training vs. endurance training in patients with chronic heart failure: a prospective randomized study Eur. Heart J., August 1, 2008; 29(15): 1858 - 1866. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. B. Nilsson, B. Hellesnes, A. Westheim, and M. A. Risberg Group-based Aerobic Interval Training in Patients With Chronic Heart Failure: Norwegian Ullevaal Model Physical Therapy, April 1, 2008; 88(4): 523 - 535. [Abstract] [Full Text] [PDF] |
||||
![]() |
M D Camargo, R Stein, J P Ribeiro, P R Schvartzman, M O Rizzatti, and B D Schaan Circuit weight training and cardiac morphology: a trial with magnetic resonance imaging Br. J. Sports Med., February 1, 2008; 42(2): 141 - 145. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Medeiros, N. P. L. Rolim, R. S. F. Oliveira, K. T. Rosa, K. C. Mattos, D. E. Casarini, M. C. Irigoyen, E. M. Krieger, J. E. Krieger, C. E. Negrao, et al. Exercise training delays cardiac dysfunction and prevents calcium handling abnormalities in sympathetic hyperactivity-induced heart failure mice J Appl Physiol, January 1, 2008; 104(1): 103 - 109. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Gao, W. Wang, D. Liu, and I. H. Zucker Exercise Training Normalizes Sympathetic Outflow by Central Antioxidant Mechanisms in Rabbits With Pacing-Induced Chronic Heart Failure Circulation, June 19, 2007; 115(24): 3095 - 3102. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. M. Conraads, P. Beckers, J. Vaes, M. Martin, V. Van Hoof, C. De Maeyer, N. Possemiers, F. L. Wuyts, and C. J. Vrints Combined endurance/resistance training reduces NT-proBNP levels in patients with chronic heart failure Eur. Heart J., October 2, 2004; 25(20): 1797 - 1805. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. Walsh, G. Yong, C. Cheetham, G. F. Watts, G. J. O'Driscoll, R. R. Taylor, and D. J. Green Effects of exercise training on conduit and resistance vessel function in treated and untreated hypercholesterolaemic subjects Eur. Heart J., September 2, 2003; 24(18): 1681 - 1689. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. Walsh, W. Bilsborough, A. Maiorana, M. Best, G. J. O'Driscoll, R. R. Taylor, and D. J. Green Exercise training improves conduit vessel function in patients with coronary artery disease J Appl Physiol, July 1, 2003; 95(1): 20 - 25. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. L. Pina, C. S. Apstein, G. J. Balady, R. Belardinelli, B. R. Chaitman, B. D. Duscha, B. J. Fletcher, J. L. Fleg, J. N. Myers, and M. J. Sullivan Exercise and Heart Failure: A Statement From the American Heart Association Committee on Exercise, Rehabilitation, and Prevention Circulation, March 4, 2003; 107(8): 1210 - 1225. [Full Text] [PDF] |
||||
![]() |
V.M. Conraads, P. Beckers, J. Bosmans, L.S. De Clerck, W.J. Stevens, C.J. Vrints, and D.L. Brutsaert Combined endurance/resistance training reduces plasma TNF-{alpha} receptor levels in patients with chronic heart failure and coronary artery disease Eur. Heart J., December 1, 2002; 23(23): 1854 - 1860. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Cheetham, D. Green, J. Collis, L. Dembo, and G. O'Driscoll Effect of aerobic and resistance exercise on central hemodynamic responses in severe chronic heart failure J Appl Physiol, July 1, 2002; 93(1): 175 - 180. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Maiorana, G. O'Driscoll, L. Dembo, C. Cheetham, C. Goodman, R. Taylor, and D. Green Effect of aerobic and resistance exercise training on vascular function in heart failure Am J Physiol Heart Circ Physiol, October 1, 2000; 279(4): H1999 - H2005. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |